DM Healthcare Investment
Asia Regenerative Medicine, Hong Kong is selected as one of the Top 100 Teams in the 2023 Alibaba JUMPSTARTER competition
July 31, 2023
HONG KONG, July 31, 2023 -- Asia Regenerative Medicine, Hong Kong has been selected to advance to the next round of the 2023 Alibaba JUMPSTARTER competition. Their project, From iPSCs to Intelligent Automated Systems for Cell Therapy Industry, aims to develop an intelligent microfluidic chip-based microencapsulation system for the delivery of cell-derived functional cells or clusters, exosomes, and an intelligent microfluidic chip-based sorting system for the analysis and sorting of a wide range of samples including stem cell-derived functional cells or clusters, exosomes, and other emulsion droplets with leading microfluidics, acoustic sorting, and AI technology. Congratulations AHK and good luck in the next round.
